ArticleTropical animal health and production2025
Seroprevalence of Akabane, border, and Rift Valley fever diseases and their risk factors in small ruminants of Fars Province, Southern Iran.
Article in Tropical animal health and production, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The Akabane virus (AKAV), Border disease virus (BDV), and Rift Valley fever virus (RVFV) are significant pathogens of ruminants, causing reproductive and neurological disorders that lead to major economic losses in the livestock industry. This study contributes to global efforts by providing valuable epidemiological insights into these three reproduction-related viruses and associated risk factors from Fars Province, a major livestock-producing area in southern Iran. Blood samples were collected from sheep and goats across 32 cities between January and December 2024. After the primary evaluation, 458 samples were tested for AKAV and BDV, and 366 samples were tested for RVFV antibodies using commercial ELISA kits. Antibodies against AKAV and BDV were detected in 59.17% (95% CI: 54.8–63.8%) and 53.49% (95% CI: 48.9–58.1%) of the samples, respectively, whereas no antibodies against RVFV were detected. The prevalence of AKAV was highest in the northern region of Fars Province (OR = 4.505, 95% CI: 2.372–8.556, p < 0.001). Of the total samples analyzed, 157 (34.4%) tested positive for both viruses. Older animals exhibited significantly higher seroprevalence rates for both AKAV (OR = 1.017, 95% CI: 1.002–1.033, p = 0.023) and BDV (OR = 1.018, 95% CI: 1.006–1.031, p = 0.004). Additionally, the prevalence of BDV was significantly higher in sheep compared to goats (OR = 1.576, 95% CI: 1.003–2.478, p = 0.025). Other factors, including sex, breed, management system, and history of abortion, showed no significant association with infection (P > 0.05). Taken together, this study revealed a high prevalence of AKAV and BDV in Fars Province, suggesting an expansion of viral circulation. Although RVFV antibodies were not detected, the virus’s zoonotic nature and reports from neighboring regions emphasize the importance of continued monitoring.
Indexed as
Identifiers
41452411What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.